Dr. Martens (DOCS)

Sector:

Personal Goods

Index:

FTSE 250

76.90p
   
  • Change Today:
    -1.25p
  • 52 Week High: 83.80p
  • 52 Week Low: 47.52p
  • Currency: UK Pounds
  • Shares Issued: 966.37m
  • Volume: 694,687
  • Market Cap: £743.14m
  • Beta: 0.00

Latest Deals

Traded Action Notifier PriceAmountValue
11-Jul-25 Transfer From Giles Wilson 0.000p 194 £0.00
11-Jul-25 Buy Giles Wilson 77.45p 194 £150.25
11-Jul-25 Transfer From Ije Nwokori 0.000p 194 £0.00
11-Jul-25 Buy Ije Nwokori 77.45p 194 £150.25
11-Jun-25 Transfer From Giles Wilson 0.000p 189 £0.00

Largest Deals (365 days)

Traded Action Notifier PriceAmountValue
24-Sep-24 Buy Robyn Perriss 51.55p 89,054 £45,907.34
24-Sep-24 Sell Robyn Perriss 51.50p 89,054 £45,862.81
24-Sep-24 Buy Andrew Harrison 51.53p 58,220 £29,999.54
27-Aug-24 Buy Lynne Weedall 74.41p 25,000 £18,603.62
25-Mar-25 Buy Giles Wilson 54.01p 32,640 £17,628.31

Director Shareholdings

Notifier Holding Value*
Paul Mason 7,875,000 £6,055,875
Giles Wilson 111,479 £85,727
Robyn Perriss 94,328 £72,538
Andrew Harrison 76,594 £58,901
Lynne Weedall 40,054 £30,802
Ian Rogers 20,270 £15,588
Ije Nwokori 6,171 £4,746

Major Shareholders

Notifier** Holding Value*
IngreLux S.àr.l 369,942,440 £284,485,736
IngreGrsy Limited 369,942,440 £284,485,736
Permira Holdings Limited 364,142,440 £280,025,536
Artemis Investment Management LLP 86,997,521 £66,901,094
Fidelity Management & Research 32,500,000 £24,992,500
Intertrust Employee Benefit Trustee Limited 135,000 £103,815

* Value is calculated by using the current share price multiplied by the amount held.
** Major Shareholders are individuals or institutions that own more than 3% of the company’s shares and have been reported in the annual accounts.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

 

Dr. Martens Market Data

Currency UK Pounds
Share Price 76.90p
Change Today -1.25p
% Change -1.60 %
52 Week High 83.80p
52 Week Low 47.52p
Volume 694,687
Shares Issued 966.37m
Market Cap £743.14m
Beta 0.00

Dr. Martens Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
22.05% below the market average22.05% below the market average22.05% below the market average22.05% below the market average22.05% below the market average
77.78% below the sector average77.78% below the sector average77.78% below the sector average77.78% below the sector average77.78% below the sector average
Price Trend
0.26% below the market average0.26% below the market average0.26% below the market average0.26% below the market average0.26% below the market average
40.00% above the sector average40.00% above the sector average40.00% above the sector average40.00% above the sector average40.00% above the sector average
Income
37.52% below the market average37.52% below the market average37.52% below the market average37.52% below the market average37.52% below the market average
Sector averageSector averageSector averageSector averageSector average
Growth
99.53% below the market average99.53% below the market average99.53% below the market average99.53% below the market average99.53% below the market average
100% below the sector average100% below the sector average100% below the sector average100% below the sector average100% below the sector average

Dr. Martens Dividends

  Latest Previous
  Final Interim
Ex-Div 28-Aug-25 06-Mar-25
Paid 08-Oct-25 08-Apr-25
Amount 1.70p 0.85p

Trades for 08-Aug-2025

Time Volume / Share Price
16:35 408,094 @ 76.90p
16:35 3,335 @ 76.90p
16:35 12,202 @ 76.90p
16:35 781 @ 76.90p
16:35 6,188 @ 76.90p

Dr. Martens Key Personnel

Chair Paul Mason
CEO Ije Nwokori
CFO Giles Wilson

Top of Page